Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1428
HR+
Luminal
IKK16
IKK
NFKB
7442.1
uM
3.40720
4.5760
-0.9894 -0.9904 3.7032 0.4440
0.9927
0.8780
HCC1428
HR+
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7444.091
uM
16.6760
26.68450
-0.9939 -1.0000 2.3369 0.5085
0.9930
0.8764
HCC1428
HR+
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7441.09
uM
16.18210
26.74840
-0.9981 -1.0000 2.1860 0.4897
0.9934
0.7331
HCC1428
HR+
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7442.092
uM
19.2520
27.09720
-0.9971 -1.0000 3.2141 0.4724
0.9966
0.7831
HCC1428
HR+
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7443.09
uM
18.27640
28.08890
-0.9897 -1.0000 2.5563 0.4713
0.9983
0.9451
HCC1428
HR+
Luminal
Ispinesib
KSP
Kinesin
7442.067
uM
0.24702
3.16120
-0.9871 -1.0000 0.4310 0.4769
0.7910
0.9126
HCC1428
HR+
Luminal
Ispinesib
KSP
Kinesin
7441.067
uM
1.76950
6.7880
-0.9951 -1.0000 0.8171 0.3267
0.8311
0.8233
HCC1428
HR+
Luminal
Ispinesib
KSP
Kinesin
7444.067
uM
0.15890
1.56350
-0.9993 -1.0000 0.4805 0.5040
0.8779
0.7382
HCC1428
HR+
Luminal
Ispinesib
KSP
Kinesin
7443.067
uM
7.49060
10.31620
-0.9841 -1.0000 3.4325 0.3014
0.9084
1.0344
HCC1428
HR+
Luminal
Ixabepilone
TUBB
TUBB
7444.095
uM
0.01732
0.72589
-0.9926 -1.0000 0.2941 0.7036
0.8142
0.8776
HCC1428
HR+
Luminal
Ixabepilone
TUBB
TUBB
7442.095
uM
0.02618
0.81312
-0.9935 -1.0000 0.3197 0.6872
0.8609
0.7851
HCC1428
HR+
Luminal
Ixabepilone
TUBB
TUBB
7443.094
uM
0.61697
1.84920
-0.9920 -1.0000 1.0008 0.7800
0.9767
0.8852
HCC1428
HR+
Luminal
JNK-IN-5A
JNK
JNK
11936.144
uM
2.56140
1.96250
0.2430 0.3680 4.9999 0.2182
0.8223
0.8864
HCC1428
HR+
Luminal
JNK-IN-5A
JNK
JNK
10693.144
uM
0.67356
0.37760
0.5424 0.4723 5.0000 0.2355
0.9438
0.8585
HCC1428
HR+
Luminal
L-779450
BRAF
MAPK
11936.161
uM
13.26490
22.41770
-0.6949 -1.0000 2.0937 0.1762
0.9719
0.7410
HCC1428
HR+
Luminal
L-779450
BRAF
MAPK
10693.149
uM
9.03840
8.69690
0.0877 0.0864 4.9274 0.0581
0.9853
0.8714
HCC1428
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7443.098
uM
inf
inf
0.9399 0.9399 0.0000 0.0425
0.0000
0.9189
HCC1428
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7442.098
uM
inf
inf
0.9599 0.9599 0.0000 0.0062
0.1962
0.8652
HCC1428
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7444.098
uM
inf
inf
0.5583 0.5583 0.0000 0.1289
0.4726
0.9681
HCC1428
HR+
Luminal
LBH589
HDAC
HDAC
11936.154
uM
0.05074
0.07168
-0.9882 -0.9944 3.1688 0.9855
0.9917
0.8259
HCC1428
HR+
Luminal
LBH589
HDAC
HDAC
10693.154
uM
0.15152
0.22481
-0.9771 -0.9815 2.7533 0.8031
0.9970
0.8696
HCC1428
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11936.154
uM
0.18173
1.67360
-0.9419 -1.0000 0.4948 0.5639
0.9284
0.8259
HCC1428
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10693.154
uM
0.56184
2.85790
-0.9305 -1.0000 0.6754 0.4432
0.9615
0.8696
HCC1428
HR+
Luminal
Mebendazole
13107.174
uM
66.7120
4.08910
0.4834 0.2783 0.2913 0.2203
0.8115
0.6723
HCC1428
HR+
Luminal
Methotrexate
DHFR
Metabolism
7443.084
uM
inf
inf
0.8105 0.8105 0.0000 0.1423
0.3953
0.9878